GPER1 and ovarian carcinoma: In contrast, Kolkova, Zuzana, et al. consider that, for patients with ovarian cancer, neither GPER mRNA nor protein predicts survival, and they do not correlate with histological or clinical parameters in patients with ovarian cancer [217].